Small mutations of the DMD gene in Taiwanese families

Journal of the Formosan Medical Association

Volumn 107, Issue 6, 2008, Pages 463-469

  Hwa, Hsiao Lin ^a,b   Chang, Yih Yuan ^c   Huang, Chien Hao ^c   Chen, Chung Hsiung ^c   Kao, Yen Shi ^c   Jong, Yuh Jyh ^d,e   Chao, Mei Chyn ^e   Ko, Tsang Ming ^a,c,f  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c Genephile Bioscience Laboratory   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f NONE   (Taiwan)

Author keywords

DNA sequence analysis; Duchenne muscular dystrophy; Dystrophin frameshift mutation; Nonsense mutation

Indexed keywords

DYSTROPHIN;

AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DUCHENNE MUSCULAR DYSTROPHY; EXON; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE DUPLICATION; GENETIC ASSOCIATION; GENETIC COUNSELING; HUMAN; MALE; MISSENSE MUTATION; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; NONSENSE MUTATION; OPEN READING FRAME; PROTEIN FUNCTION; RNA SPLICING; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; STOP CODON; TAIWAN;

EID: 48049098511     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(08)60154-0     Document Type: Article

References (24)

1. Emery AE. Population frequencies of inherited neuromuscular diseases: a world survey. Neuromuscul Disord 1991;1: 19-29.
2. Mandel JL. Dystrophin. The gene and its product. Nature 1989;339:584-6.
3. Koenig M, Hoffman EP, Berteison CJ, et al. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987;50:509-17.
4. Muntoni F, Torelli S, Ferlini A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2003; 2:731-40.
5. Aartsma-Rus A, Van Deutekom JCT, Fokkema IF, et al. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve 2006;34:135-44.
6. den Dunnen JT. Leiden Muscular Dystrophy Pages, Center for Human and Clinical Genetics, Leiden University Medical Center. Dystrophin database. Available at: http://www.dmd.nl. [Date accessed: June 7, 2007]
7. Schwartz M, Morten D. Improved molecular diagnosis of dystrophin gene mutations using the multiplex ligation-dependent probe amplification methods. Genetic Testing 2004;8:361-7.
8. Lai KK, Lo IF, Tong TM, et al. Detecting exon deletions and duplications of the DMD gene using multiplex ligation-dependent probe amplification (MLPA). Clin Biochem 2006;39:367-72.
9. Hwa HL, Chang YY, Huang CH, et al. Multiplex ligation-dependent probe amplification identification of deletions and duplications of the Duchenne muscular dystrophy gene in Taiwanese subjects. J Formos Med Assoc 2007;106: 339-46.
10. Prior TW, Bridgeman SJ. Experience and strategy for the molecular testing of Duchenne muscular dystrophy. J Mol Diagn 2005;7:317-26.
11. HUGO Mutation Database Initiative. The Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff. Available at: http://www.hgmd.cf.ac.uk/ac/index.php [Date accessed: June 22, 2007]
12. Hofstra RM, Mulder IM, Vossen R, et al. DGGE-based whole-gene mutation scanning of the dystrophin gene in Duchenne and Becker muscular dystrophy patients. Hum Mutat 2004;23:57-66.
13. Lenk U, Oexle K, Voit T, et al. A cysteine 3340 substitution in the dystroglycan-binding domain of dystrophin associated with Duchenne muscular dystrophy, mental retardation and absence of the ERG b-wave. Hum Mol Genet 1996; 5:973-5.
14. Le Maire C, Heilig R, Mandel JL. The chicken dystrophin cDNA: striking conservation of the C-terminal coding and 3′ untranslated regions between man and chicken. EMBO J 1988;7:4157-62.
15. Buzin CH, Feng J, Yan J, et al. Mutation rates in the dystrophin gene: a hotspot of mutation at a CpG dinucleotide. Hum Mutat 2005;25:177-88.
16. Mendell JR, Buzin CH, Feng J, et al. Diagnosis of Duchenne dystrophy by enhanced detection of small mutations. Neurology 2001;57:645-50.
17. Deburgrave N, Daoud F, Llense S, et al. Protein- and mRNA-based phenotype-genotype correlations in DMD/BMD with point mutations and molecular basis for BMD with nonsense and frameshift mutations in the DMD gene. Hum Mutat 2007;28:183-95.
18. Ozawa E, Yoshida M, Suzuki A, et al. Dystrophin-associated proteins in muscular dystrophy. Hum Mol Genet 1995;4: 1711-6.
19. Cooper DN, Kwrawczak M, Antonarakis SE. The nature and mechanism of human gene mutation. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The Metabolic and Molecular Bases of Inherited Disease, Volume 1, 7th edition. New York: McGraw-Hill, 1995:259-92.
20. Suzuki A, Yoshida M, Ozawa E. Mammalian alpha 1- and beta 1-syntrophin bind to the alternative splice-prone region of the dystrophin COOH-terminus. J Cell Biol 1995;128: 373-81.
21. Tuffery-Giraud S, Chambert S, Demaille J, et al. Point mutations in the dystrophin gene: evidence for frequent use of cryptic splice sites as a result of splicing defects. Hum Mutat 1999;14:359-68.
22. Krawczak M, Reiss J, Cooper DN. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 1992;90:41-54.
23. Crispino JD, Mermoud JE, Lamond AI, et al. Cis-acting elements distinct from the 5′ splice site promote U1-independent pre-mRNA splicing. RNA 1996;2:664-73.
24. Basic Local Alignment Search Tool. Available at: http://www.ncbi.nlm.nih.gov/BLAST/ [Date accessed: May 30, 2007]